News
A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on Friday. Roughly 15 million people — six percent of adults in the United States — have metabolic dysfunction-associated steatohepatitis, known as MASH. Rates of the disease are rising.
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
U.S. health officials gave the Food and Drug Administration the power to quickly authorize veterinarians and farmers to treat ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
The FDA urged consumers not to use the foam-style products because they may not be effective in protecting the skin from the ...
Rocket Pharmaceuticals said on Wednesday that the U.S. Food and Drug Administration has lifted the clinical hold on its gene ...
The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent ...
Only 53% of Americans say they have a “great deal” or “fair amount” of confidence in food safety. This number has been ...
The U.S. Food and Drug Administration reportedly secretly allowed substandard foreign factories to ship hundreds of ...
Bristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback